Fig. 2
Network of clinical trials on oral antidiabetic drugs or placebo in patients with type 2 diabetes. Lines connect the interventions that have been studied in head-to-head comparisons in eligible RCTs. The width of the lines represents the total number of RCTs for each pairwise comparison. The size of every node is proportional to the number of randomized participants